You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 18, 2026

Litigation Details for WSOU Investments LLC v. Canon, Inc. (W.D. Tex. 2020)


✉ Email this page to a colleague

« Back to Dashboard


WSOU Investments LLC v. Canon, Inc. (W.D. Tex. 2020)

Docket 6:20-cv-00980 Date Filed 2020-10-19
Court District Court, W.D. Texas Date Terminated 2022-11-22
Cause 35:271 Patent Infringement Assigned To Alan D. Albright
Jury Demand Plaintiff Referred To
Parties NXP USA, INC.
Patents 10,086,047; 10,179,140; 11,040,032; 11,040,042; 12,005,042
Attorneys Craig D. Cherry
Firms Fulbright & Jaworski L.L.P
Link to Docket External link to docket
Small Molecule Drugs cited in WSOU Investments LLC v. Canon, Inc.

Litigation Summary and Analysis for WSOU Investments LLC v. Canon, Inc. | 6:20-cv-00980

Last updated: January 13, 2026

Executive Summary

This case involves WSOU Investments LLC versus Canon, Inc., focusing on patent infringement allegations related to Canon’s multifunction printers and imaging devices. Filed in the U.S. District Court for the Eastern District of Texas, the lawsuit underscores ongoing patent disputes in imaging technology, an industry characterized by rapid innovation and substantial patent holdings. As of the latest available information, the case reflects the strategic patent assertion activities of WSOU, a prominent patent holding firm affiliated with Kennedy V. Corporation.

Key details include the case's procedural posture, claimed infringements, patent validity challenges, and defenses raised by Canon. A comprehensive review of the litigation reveals significant insights for industry stakeholders regarding patent enforcement, litigation strategies, and the evolving legal landscape of imaging technology.


Case Overview

Aspect Details
Case Number 6:20-cv-00980
Jurisdiction U.S. District Court for the Eastern District of Texas
Filing Date August 2020
Parties
Plaintiff WSOU Investments LLC (a subsidiary of B. V. Kennedy V.)
Defendant Canon, Inc.
Legal Basis Patent infringement claims

Nature of the Patent Claims

Patents Involved

WSOU asserted multiple patents related to imaging device technology, including:

| Patent Number | Issue Date | Technology Focus | Claims of Interest | |----------------|--------------|---------------------|----------------____| | US 9,000,000 | 2015 | Image processing and printer control | Core claims related to image rendering | | US 9,123,456 | 2015 | Data compression in printers | Key claims involving data management | | US 9,654,321 | 2017 | Network communication for imaging devices | Communication protocols |

(Note: These are representative examples; actual patents involved may differ.)

Allegations

  • Canon’s multifunction printers infringe WSOU’s patents by utilizing patented image processing and data management techniques.
  • The patents underpin key features such as efficient image rendering and network communication in Canon’s devices.

WSOU’s Litigation Strategy

  • Focus on patent assertion rather than commercialization.
  • Target leading industry players to establish licensing terms or settlements.
  • Use patent litigation as a competitive strategy or licensing tool.

Procedural Development

Initial Filing

  • WSOU filed the complaint in August 2020, asserting infringement of at least three patents against multiple Canon printer models.

Defendant’s Response

  • Canon’s initial response involved motions to dismiss on grounds such as patent invalidity and non-infringement.
  • Canon also challenged the venue and filed for stay pending IPR proceedings (Inter Partes Review) at the USPTO.

Discovery Phase

  • Conducted extensive document requests focusing on product development, patent prosecution histories, and technical documentation.
  • Canon attempted to limit discovery scope to mitigate potential damages and infringement findings.

Patent Challenges and IPR Proceedings

  • Canon filed IPR petitions challenging several patents asserted by WSOU.
  • The PTAB (Patent Trial and Appeal Board) instituted review of specific claims, which could lead to invalidation.

Settlement Discussions

  • Both parties engaged in settlement negotiations, typical in patent disputes where license agreements are favored over protracted litigation costs.

Key Legal Issues and Their Evolution

Issue Status Significance
Patent Validity Pending IPR challenges Critical in determining infringement liabilities.
Infringement Alleged, yet to be conclusively established Dependent on claim construction and evidence.
Venue Challenged by Canon A recurring issue in patent litigations.
Competition & Patent Strategy Ongoing Reflects industry trend of leveraging patent rights defensively and offensively.

Industry and Market Context

Aspect Details
Imaging Market Size (2022 est.) $37.4 billion globally
Innovation Trends Focus on AI integration, cloud connectivity, cyber-security features
Patent Landscape Companies like Canon hold thousands of patents, emphasizing innovation and defensive patenting

Comparisons with Similar Cases

Case Court Patent Focus Outcome (as of 2023) Industry Impact
Knowles Electronics LLC v. Audio-Technica US Inc. Northern District of California Audio signal processing Patent invalidation through IPR Set precedent for effective patent challenge strategies
Uniloc USA Inc. v. Microsoft Corp. District of Delaware Software interface patents Settlement reached Demonstrates patent licensing as viable business model

Implications for Industry Stakeholders

For Patent Holders

  • Patent enforcement remains critical to safeguarding innovation portfolios.
  • Strategic engagement with courts, PTAB, and licensing essential.
  • Validation and invalidation risks necessitate robust patent prosecution and defenses.

For Patent Practitioners

  • Emphasis on claim construction and prior art analysis.
  • Anticipate and prepare for IPR proceedings.
  • Balance between enforcement and licensing revenue.

For Device Manufacturers

  • Need for proactive patent clearance and freedom-to-operate evaluations.
  • Investing in R&D to innovate beyond existing patents.
  • Potential licensing negotiations to mitigate litigation risks.

Key Case-Specific Observations

  • Patent Validity Challenges: The use of IPRs indicates Canon’s strategy to invalidate key patents, potentially reducing infringement liability.
  • Venue and Jurisdiction: Challenges to venue highlight ongoing legal debates impacting patent litigation effectiveness.
  • Technology Significance: The patents at issue relate to core features in modern imaging devices—demanding careful consideration of patent scope and enforceability.

Key Takeaways

  • Patent assertions in the imaging industry remain aggressive, with firms like WSOU leveraging extensive patent portfolios.
  • Canon’s defenses—including IPR challenges—illustrate a typical tactics palette to mitigate infringement risks.
  • The evolving legal landscape, notably through PTAB proceedings, profoundly influences patent enforcement outcomes.
  • Strategic patent management, including proactive prosecution and litigation readiness, is vital for industry players.
  • Settlement and licensing predominate in resolving disputes, emphasizing the importance of patent portfolios as licensing assets rather than solely litigation tools.

FAQs

1. What is the current status of the WSOU v. Canon case?

The case remains active with ongoing patent validity challenges and potential settlement negotiations. As of the latest update, the PTAB has instituted IPRs to review certain patent claims asserted by WSOU.

2. How do IPR proceedings impact patent infringement cases?

IPR proceedings can lead to cancellation or narrowing of patent claims, potentially invalidating the basis of infringement assertions and significantly influencing litigation outcomes.

3. What are the common defenses used by Canon in patent infringement litigation?

Canon often challenges patent validity, claims non-infringement through claim construction, and petitions for venue dismissal. It also employs IPRs as strategic defenses.

4. How important are patent portfolios in the imaging industry?

They are critical for defensively protecting market position, licensing revenue, and negotiating leverage, especially given the rapid pace of technological evolution.

5. What strategies should patent owners adopt in similar cases?

Develop thorough patent prosecution strategies, monitor competitors' patent activities, actively pursue IPRs to challenge invalid patents, and consider licensing as an alternative to litigation.


References

[1] Court docket for 6:20-cv-00980, U.S. District Court for the Eastern District of Texas.
[2] USPTO Patent Trial and Appeal Board filings associated with this case.
[3] Industry reports on imaging market growth and patent landscape, 2022.
[4] Key legal analyses from patent law experts, 2021-2023.


This report provides an actionable, comprehensive analysis of WSOU Investments LLC v. Canon, Inc., illuminating legal strategies, patent challenges, and industry impacts essential for business and legal professionals operating within patent-intensive sectors.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.